Effect of delayed pMDI actuation on the lung deposition of a fixed-dose combination aerosol drug
Authors:
- 1 August 2018
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 547 (1-2) , 480-488
Abstract
No abstract availableKeywords
Funding Information
- Magyar Tudományos Akadémia
This publication has 33 references indexed in Scilit:
- Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Validating CFD predictions of respiratory aerosol deposition: Effects of upstream transition and turbulenceJournal of Biomechanics, 2007
- Influence of Particle Size and Patient Dosing Technique on Lung Deposition of HFA-Beclomethasone from a Metered Dose InhalerJournal of Aerosol Medicine, 2005
- Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary CareJournal of Aerosol Medicine, 2003
- Laminar-to-turbulent fluid-particle flows in a human airway modelInternational Journal of Multiphase Flow, 2003
- Respiratory Deposition Patterns of Salbutamol pMDI with CFC and HFA-134a Formulations in a Human Airway ReplicaJournal of Aerosol Medicine, 2001
- Particle Deposition in a Cast of Human Oral AirwaysAerosol Science and Technology, 1999
- Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.Thorax, 1995
- Morphometry of the human pulmonary acinusThe Anatomical Record, 1988
- Pressurized aerosol inhaler technique: How important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs?Respiratory Medicine, 1983